Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
PTGX
PTGX News & Events
-
Add to Watchlist
Trade PTGX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
PTGX News
Johnson & Johnson Divests from 3 Biotech Companies While Retaining Investments in Potential Acquisition Candidates
Mar 25 2026
Barron's
Insider at Protagonist Therapeutics (PTGX.US) Plans to Sell $5.39 Million in Common Stock via Form 144
Mar 24 2026
moomoo
RTW Investments Takes New Stake in Apellis Pharmaceuticals
Mar 22 2026
Yahoo Finance
RTW Investments Increases Stake in Cogent Biosciences by $116 Million
Mar 22 2026
Yahoo Finance
Icotyde Receives FDA Approval, Protagonist Hits Milestone
Mar 18 2026
stocktwits
Johnson & Johnson's Icotyde Receives FDA Approval
Mar 18 2026
CNBC
Johnson & Johnson's Icotyde Approved by FDA for Psoriasis
Mar 18 2026
Newsfilter
Johnson & Johnson's Icotyde Approved by FDA for Plaque Psoriasis
Mar 18 2026
seekingalpha
Show More News
PTGX Events
No data
PTGX Monitor News
Protagonist Therapeutics Receives Milestone Payment After FDA Approval of Icotyde
Mar 19 2026
PTGX Earnings Analysis
No Data
People Also Watch
